Evidence map›Paper›PMID 36875734›Full record

ArticleTobacco induced diseases2023

Pod-based e-cigarette use among US college-aged adults: A survey on the perception of health effects, sociodemographic correlates, and interplay with other tobacco products.

Olufunmilayo H Obisesan, S M Iftekhar Uddin, Ellen Boakye, Albert D Osei, Mohammadhassan Mirbolouk, Olusola A Orimoloye, Omar Dzaye, Omar El Shahawy, Andrew Stokes, Andrew P DeFilippis and 2 more

Open access · goldAbstract read
In one paragraph

Article in Tobacco induced diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Olufunmilayo H ObisesanThe Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Baltimore, United States.
S M Iftekhar UddinThe Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Baltimore, United States.
Ellen BoakyeThe Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Baltimore, United States.
Albert D OseiDepartment of Medicine, Medstar Union Memorial Hospital, Baltimore, United States.
Mohammadhassan MirboloukDepartment of Medicine, Yale New Haven Hospital, New Haven, United States.
Olusola A OrimoloyeDepartment of Medicine, Vanderbilt University Medical Center, Nashville, United States.
Omar DzayeThe Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Baltimore, United States.
Omar El ShahawyThe American Heart Association Tobacco Regulation and Addiction Center, Dallas, United States.
Andrew StokesThe American Heart Association Tobacco Regulation and Addiction Center, Dallas, United States.
Andrew P DeFilippisThe American Heart Association Tobacco Regulation and Addiction Center, Dallas, United States.
Emelia J BenjaminThe American Heart Association Tobacco Regulation and Addiction Center, Dallas, United States.
Michael J BlahaThe Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Baltimore, United States.
American Heart Association · USBoston University · USMedStar Union Memorial Hospital · USVanderbilt University Medical Center · USYale New Haven Hospital · US

Funding

PATHOPHYSIOLOGY OF MYOCARDIAL DISEASEST32HL007227 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Chulan Kwon, WENDY S POST · 1985 to 2026
$21.2M
Novel Methods for Evaluating the Association of Electronic Cigarette Use with Cardiovascular HealthK01HL154130 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI STOKES, ANDREW · 2020 to 2024
$904k
NHLBI NIH HHS K01 HL154130NHLBI NIH HHS T32 HL007227
6 · The paper itself

Abstract

introductionE-cigarette use among youth and young adults remains of public health concern. Pod-based e-cigarettes, including JUUL, significantly changed the e-cigarette landscape in the US. Using an online survey, we explored the socio-behavioral correlates, predisposing factors, and addictive behaviors, among young adult pod-mod users within a University in Maryland, USA.

methodsIn total, 112 eligible college students aged 18-24 years, recruited from a University in Maryland, who reported using pod-mods were included in this study. Participants were categorized into current/non-current users based on past-30-day use. Descriptive statistics were used to analyze participants' responses.

resultsThe mean age of the survey participants was 20.5 ± 1.2 years, 56.3% were female, 48.2% White, and 40.2% reported past-30-day (current) use of pod-mods. The mean age of first experimentation with pod-mods was 17.8 ± 1.4 years, while the mean age of regular use was 18.5 ± 1.4 years, with the majority (67.9%) citing social influence as the reason for initiation. Of the current users, 62.2% owned their own devices, and 82.2% predominantly used JUUL and menthol flavor (37.8%). A significant proportion of current users (73.3%) reported buying pods in person, 45.5% of whom were aged <21 years. Among all participants, 67% had had a past serious quit attempt. Among them, 89.3% neither used nicotine replacement therapy nor prescription medications. Finally, current use (adjusted odds ratio, AOR=4.52; 95% CI: 1.76-11.64), JUUL use (AOR=2.56; 95% CI: 1.08-6.03), and menthol flavor (AOR=6.52; 95% CI: 1.38-30.89) were associated with reduced nicotine autonomy, a measure of addiction.

conclusionsOur findings provide specific data to inform the development of public health interventions targeted at college youth, including the need for more robust cessation support for pod-mod users.

Indexed as

collegee-cigaretteselectronic nicotine delivery devicesENDSpod-mods

Identifiers

PMID36875734
PMCPMC9983309
OpenAlexW4323041264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.